» Articles » PMID: 36814844

Embracing Enzyme Promiscuity with Activity-based Compressed Biosensing

Overview
Specialty Cell Biology
Date 2023 Feb 23
PMID 36814844
Authors
Affiliations
Soon will be listed here.
Abstract

The development of protease-activatable drugs and diagnostics requires identifying substrates specific to individual proteases. However, this process becomes increasingly difficult as the number of target proteases increases because most substrates are promiscuously cleaved by multiple proteases. We introduce a method-substrate libraries for compressed sensing of enzymes (SLICE)-for selecting libraries of promiscuous substrates that classify protease mixtures (1) without deconvolution of compressed signals and (2) without highly specific substrates. SLICE ranks substrate libraries using a compression score (), which quantifies substrate orthogonality and protease coverage. This metric is predictive of classification accuracy across 140 (Pearson  = 0.71) and 55 libraries ( = 0.55). Using SLICE, we select a two-substrate library to classify 28 samples containing 11 enzymes in plasma (area under the receiver operating characteristic curve [AUROC] = 0.93). We envision that SLICE will enable the selection of libraries that capture information from hundreds of enzymes using fewer substrates for applications like activity-based sensors for imaging and diagnostics.

Citing Articles

AND-gated protease-activated nanosensors for programmable detection of anti-tumour immunity.

Sivakumar A, Phuengkham H, Rajesh H, Mac Q, Rogers L, Silva Trenkle A Nat Nanotechnol. 2025; .

PMID: 39753733 DOI: 10.1038/s41565-024-01834-8.


Description of an activity-based enzyme biosensor for lung cancer detection.

Dempsey P, Sandu C, Gonzalezirias R, Hantula S, Covarrubias-Zambrano O, Bossmann S Commun Med (Lond). 2024; 4(1):37.

PMID: 38443590 PMC: 10914759. DOI: 10.1038/s43856-024-00461-7.


Protease Activity Analysis: A Toolkit for Analyzing Enzyme Activity Data.

Soleimany A, Martin-Alonso C, Anahtar M, Wang C, Bhatia S ACS Omega. 2022; 7(28):24292-24301.

PMID: 35874224 PMC: 9301967. DOI: 10.1021/acsomega.2c01559.

References
1.
Finn N, Kemp M . Systems biology approaches to enzyme kinetics: analyzing network models of drug metabolism. Methods Mol Biol. 2014; 1113:317-34. DOI: 10.1007/978-1-62703-758-7_15. View

2.
ODonoghue A, Eroy-Reveles A, Knudsen G, Ingram J, Zhou M, Statnekov J . Global identification of peptidase specificity by multiplex substrate profiling. Nat Methods. 2012; 9(11):1095-100. PMC: 3707110. DOI: 10.1038/nmeth.2182. View

3.
Mac Q, Sivakumar A, Phuengkham H, Xu C, Bowen J, Su F . Urinary detection of early responses to checkpoint blockade and of resistance to it via protease-cleaved antibody-conjugated sensors. Nat Biomed Eng. 2022; 6(3):310-324. PMC: 8957521. DOI: 10.1038/s41551-022-00852-y. View

4.
Olson O, Joyce J . Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response. Nat Rev Cancer. 2015; 15(12):712-29. DOI: 10.1038/nrc4027. View

5.
Holt B, Tuttle M, Xu Y, Su M, Roise J, Wang X . Dimensionless parameter predicts bacterial prodrug success. Mol Syst Biol. 2022; 18(1):e10495. PMC: 8744131. DOI: 10.15252/msb.202110495. View